Clinical Trial Update: Safety and Efficacy of Express LD to Treat Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of Express LD to treat stenosed or occlusive atherosclerotic disease in the iliac arteries has completed. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Iliac Artery Disease
• Peripheral Artery Disease

Drugs mentioned

• Express LD

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Arterial Occlusive Disease, Intermittent Claudication | Phase 3 | Status: COMPLETED